# Cortisol Regulates PD‐1 and IL‐12 in Canine Leishmaniasis

**Authors:** Lucas Takeshi Siqueira Ito, Gisele Mitsue Umino, Mayla Abbas Guimarães, Bianca Maciel Marques de Souza, Sofia Furrier Soares, Luiz Eduardo Amador Loiola Pereira, Valéria Marçal Felix de Lima

PMC · DOI: 10.1111/pim.70062 · Parasite Immunology · 2026-02-02

## TL;DR

This study shows that cortisol levels are elevated in dogs with leishmaniasis, which may affect immune responses and disease progression.

## Contribution

The study is the first to report HPA axis dysregulation in canine leishmaniasis and its link to immune markers.

## Key findings

- Cortisol levels were higher and ACTH levels were lower in dogs with leishmaniasis.
- Cortisol negatively correlated with PD-1 and IL-12 in infected dogs.
- Increased expression of iNOS, arginase-1, and PD-1 was observed in PBMC of infected dogs.

## Abstract

Canine visceral leishmaniasis (CanL) is a tropical zoonosis caused by Brazil's protozoan Leishmania (L.) infantum. Disorders in the hypothalamic–pituitary–adrenal (HPA) axis have been reported in human and experimental visceral leishmaniasis, but not yet in canine leishmaniasis. Cortisol is a steroid hormone that regulates several processes, including immune responses. This study investigated HPA axis disorders in dogs with visceral leishmaniasis and their link to clinical and immunological parameters. ELISA quantified serum levels of cortisol and adrenocorticotrophic hormone (ACTH) in 12 healthy dogs and 13 dogs with leishmaniasis. The expression of the enzymes inducible nitric oxide synthase (iNOS) and arginase‐1 and programmed cell death protein‐1 (PD‐1) were evaluated by flow cytometry in peripheral blood mononuclear cells (PBMC). Additionally, serum levels of the cytokines interleukin (IL)‐1β, IL‐6, IL‐10, IL‐12, interferon‐gamma (IFN‐γ), tumour necrosis factor‐alpha (TNF‐α), and transforming growth factor‐beta (TGF‐β) were quantified by capture Enzyme‐Linked Immunosorbent Assay (ELISA). Parasite load was quantified in peripheral blood and conjunctival swabs by real‐time polymerase chain reaction (qPCR). All parameters evaluated were correlated with serum cortisol. We observed an increase in cortisol, while ACTH levels were reduced in dogs with leishmaniasis. The expression of iNOS, arginase‐1 and PD‐1 was higher in the PBMC of dogs with leishmaniasis. Serum levels of the cytokines IL‐10, IL‐6, IL‐12, and IFN‐γ were increased in dogs with leishmaniasis. Cortisol showed a negative correlation with PD‐1 and IL‐12. Our findings suggest that infection natural with L. infantum in dogs may induce dysregulation of the HPA axis, leading to elevated serum cortisol levels and modulation of the immune response, as it is associated with immunological markers involved in disease pathogenesis. These results contribute to a better understanding of the pathogenic mechanisms of the disease.

## Linked entities

- **Proteins:** NOS2 (nitric oxide synthase 2), Arg1 (arginase 1), PDCD1 (programmed cell death 1), IL1B (interleukin 1 beta), IL6 (interleukin 6), IL10 (interleukin 10), IL12 (Interleukin 12 level), IFNG (interferon gamma), TNF (tumor necrosis factor), TGFB1 (transforming growth factor beta 1)
- **Diseases:** leishmaniasis (MONDO:0011989)

## Full-text entities

- **Genes:** Nos2 (nitric oxide synthase 2, inducible) [NCBI Gene 18126] {aka MAC-NOS, NOS-II, Nos-2, Nos2a, i-NOS, iNOS}, IFNG (interferon gamma) [NCBI Gene 403801] {aka IFN-G, IFN-gamma}, IL4 (interleukin 4) [NCBI Gene 403785] {aka IL-4}, IL6 (interleukin 6) [NCBI Gene 403985] {aka IL-6}, POMC (proopiomelanocortin) [NCBI Gene 403659] {aka ACTH}, NOS2 (nitric oxide synthase 2) [NCBI Gene 403822] {aka INOS, NOS2A}, TBX21 (T-box transcription factor 21) [NCBI Gene 491044], TGFB1 (transforming growth factor beta 1) [NCBI Gene 403998], PDCD1 (programmed cell death 1) [NCBI Gene 486213] {aka PD-1}, GC (GC vitamin D binding protein) [NCBI Gene 475172], STAT3 (signal transducer and activator of transcription 3) [NCBI Gene 490967], NR3C1 (nuclear receptor subfamily 3 group C member 1) [NCBI Gene 478047] {aka GR}, IL2 (interleukin 2) [NCBI Gene 403989], MC2R [NCBI Gene 483980], CRH (corticotropin releasing hormone) [NCBI Gene 486977], JUN (Jun proto-oncogene, AP-1 transcription factor subunit) [NCBI Gene 609429] {aka AP-1, c-jun}, ARG1 (arginase 1) [NCBI Gene 474823], STAT4 (signal transducer and activator of transcription 4) [NCBI Gene 478845], ALB (albumin) [NCBI Gene 403550] {aka CSA}, CD4 (CD4 molecule) [NCBI Gene 403931], Trav6-3 (T cell receptor alpha variable 6-3) [NCBI Gene 328483] {aka Gm13948, Gm193, Gm4, TCR}, TNF (tumor necrosis factor) [NCBI Gene 403922] {aka TNFA, TNLG1F, cTNF}, MC2R (melanocortin 2 receptor) [NCBI Gene 100855756], ALPL (alkaline phosphatase, biomineralization associated) [NCBI Gene 403548] {aka ALP}, IL1B (interleukin 1 beta) [NCBI Gene 403974] {aka IL-1}, MYD88 (MYD88 innate immune signal transduction adaptor) [NCBI Gene 477024], IL10 (interleukin 10) [NCBI Gene 403628] {aka IL-10}
- **Diseases:** cancer (MESH:D009369), periocular lesions (MESH:D019557), Infectious diseases (MESH:D003141), thrombocytopenia (MESH:D013921), rheumatoid arthritis (MESH:D001172), cachexia (MESH:D002100), CanL (MESH:D007898), tuberculosis (MESH:D014376), seborrhea (MESH:D012628), HPA axis disorders (MESH:D007029), infected (MESH:D007239), hepatosplenomegaly (MESH:C535727), anaemia (MESH:D000743), Leishmaniasis (MESH:D007896), chronic renal insufficiency (MESH:D051436), skin and periocular lesions (MESH:D012871), inflammation (MESH:D007249), Chagas disease (MESH:D014355), lymphadenopathy (MESH:D008206), hypoalbuminemia (MESH:D034141), glomerular damage (MESH:D007674), uremia (MESH:D014511), parasitic diseases (MESH:D010272), alopecia (MESH:D000505), viral diseases (MESH:D014777), weight loss (MESH:D015431), immunological dysfunctions (MESH:D007154), malaria (MESH:D008288), ophthalmic disorders (MESH:C535922)
- **Chemicals:** L-glutamine (MESH:D005973), cortisone (MESH:D003348), K2EDTA (-), NO (MESH:D009569), DPP (MESH:C038694), creatinine (MESH:D003404), lipophosphoglycan (MESH:C008290), dexamethasone (MESH:D003907), superoxide (MESH:D013481), polyamines (MESH:D011073), heparin (MESH:D006493), FL (MESH:D005459), prostaglandin E2 (MESH:D015232), Cortisol (MESH:D006854), 15-keto-PGE2 (MESH:C026346), L-ornithine (MESH:D009952), SYBR Green (MESH:C098022), FA (MESH:D005492), LPS (MESH:D008070), hydrogen peroxide (MESH:D006861), Water (MESH:D014867), penicillin (MESH:D010406), DHEA (MESH:D003687), streptomycin (MESH:D013307), urea (MESH:D014508), FITC (MESH:D016650), steroid hormone (MESH:D013256), reactive oxygen species (MESH:D017382)
- **Species:** Toxoplasma gondii (species) [taxon 5811], Canis lupus familiaris (dog, subspecies) [taxon 9615], Trypanosoma brucei (species) [taxon 5691], Leishmania chagasi (species) [taxon 44271], Leishmania infantum (species) [taxon 5671], Ehrlichia (genus) [taxon 943], Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116], Cricetinae (hamsters, subfamily) [taxon 10026], Leishmania donovani (species) [taxon 5661], Neospora caninum (species) [taxon 29176], Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** CanL — Canis lupus familiaris (Dog), Canine mastocytoma, Cancer cell line (CVCL_WH43)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12862539/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12862539/full.md

## References

82 references — full list in the complete paper: https://tomesphere.com/paper/PMC12862539/full.md

---
Source: https://tomesphere.com/paper/PMC12862539